does glp-1 help with inflammation The anti-inflammatory and immunological properties of Receptor Agonists The Therapeutic Potential of GLP-1

A review of the FDA adverse event database revealed an increased incidence of thyroid cancer with exenatide whn compared with a control drug ( J Clin Endocrinol Metabolism

It is currently the phase II drug associated with the greatest weight reduction, achieving a 24% decrease (28.5% in women) after 48 weeks with a weekly dose of 12 mg55 (Table 1), and providing significant benefits in the control of cardiovascular risk factors and the reduction of MASLD56 (Fig

4 Oral GLP-1 race is accelerating Context matters: Novo Nordisk already launched oral Wegovy Eli Lilly and Company is nearing a regulatory decision for orforglipron AstraZeneca licensed elecoglipron from Eccogene in 2023 Public scrutiny is rising, highlighted by the hims & hers controversy This is now a three-horse global race, not an experiment

NICE guidance emphasises individualised treatment approaches, and your healthcare team can work with you to optimise therapy whilst minimising troublesome side effects

If you had come across the abbreviation GLP-1 a few years ago, chances are youd have had no idea what it stood for

This move further strengthens Ingredions position in the fast-growing prebiotics and functional ingredients space